Anal carcinoma
MONDO:0003199A carcinoma that arises from epithelial cells of the anus
Also known as: Ca anus, anal cancer, cancer of anus, cancer of the anus, anal carcinoma, anus carcinoma, carcinoma of anus, carcinoma of the anus
3010 clinical trials for this condition and its sub-types, 85 tagged with Anal carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Anal carcinoma
-
Anal squamous cell carcinoma 40 trials · 49 incl. sub-types
4 sub-types
- Anal canal squamous cell carcinoma 12 trials
- Anal margin squamous cell carcinoma 4 trials
- Anus basaloid carcinoma 3 trials
- Anal verrucous carcinoma 0 trials
-
Anal canal carcinoma 4 trials · 34 incl. sub-types
5 sub-types
- Anal canal carcinoma in situ 12 trials
- Anal canal squamous cell carcinoma 12 trials
- Cloacogenic carcinoma 10 trials
- Anal canal adenocarcinoma 0 trials · 1 incl. sub-types Sub-types →
- Anal canal neuroendocrine neoplasm 1 trial Sub-types →
-
Anal margin carcinoma 1 trial · 6 incl. sub-types
3 sub-types
- Anal margin squamous cell carcinoma 4 trials
- Perianal skin Paget disease 1 trial
- Anal margin basal cell carcinoma 0 trials
-
Anus adenocarcinoma 0 trials · 1 incl. sub-types
4 sub-types
- Anal Paget disease 1 trial Sub-types →
- Anal canal adenocarcinoma 0 trials · 1 incl. sub-types Sub-types →
- Anal gland adenocarcinoma 0 trials
- Anal mucinous adenocarcinoma 0 trials
Most studied deeper sub-types
-
Experimental cancer combo shows early promise but study halted
Disease control Stopped earlyThis early-phase trial tested a new drug called nanrilkefusp alfa, which helps activate immune cells, both alone and combined with the immunotherapy pembrolizumab. It included 115 people with various advanced solid tumors that had stopped responding to standard treatments. The st…
Phase 1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental drug targets Hard-to-Treat cancers, but trial ends early
Disease control Stopped earlyThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow cancer growth. The trial was terminat…
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
HIV cancer hope: immune combo shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who had advanced solid tumors or Hodgkin lymphoma that had spread or come back. The goal was to find the safest dose and see if the combination could shrink tumors. The study was t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Battle of the scalpels: which surgery is best for early rectal cancer?
Disease control Stopped earlyThis study compared two procedures for removing early-stage rectal cancer or precancerous growths: endoscopic submucosal dissection (ESD) and transanal endoscopic microsurgery (TEM). Both are less invasive than traditional surgery. The goal was to see which one removes the tumor …
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Experimental cancer drug trial ends early
Disease control Stopped earlyThis early-stage study tested an experimental drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC